Need a comment on this..
I found this in another board.. Can ypu please comment?
----
Quick Question
I have been researching, at length, the potential and or possible strategies that IBS holds for the future, and wether or not they include Sproutly. I can not locate any deals other than Alkaline and TrueAerogrow. In his speech at the summit, Dr Sen mentions Unilever but this relation remains to be discovered. The time lines I have indicate that these deals were all pre Sproutly.
Throughout my research, I continue to wonder how Dr Sen and IBS will make deals in any near future without licensing or applications there of. THR holds the ACMPR/LP Licensing for Sproutly as it’s subsidiary. However, I can not locate any licensing for IBS or any subsidiaries. To my knowledge, IBS holds no licensing for LP or research development anywhere cannabis and or Hemp is legal and or illegal. Which is odd, because Dr Sen was fine tuning his work in Washington. I can not locate any records of licensing for IBS for the deals he made in the US. Can an unlicensed 2nd or 3rd party process cannabis for a licensed LP in the US legalized states?
Sure, when the US(Non Legal States)and other countries evolve, IBS may then apply for licensing. However, if the process to obtain a licence is anything like we have seen in the currently legal US states and Canada, this could take a substantial amount of time, years perhaps. Where will the INFUZ2o come from for the immediate needs of these US companies? This is where I feel Sproutly will hold value for IBS, as they will have ample supply on hand and hold position to allow licenced distributors to make the purchase from IBS and products, INFUZ2o/Bio Oil, will be produced by Sproutly/THR.
My conclusion thus far until new info comes to light, Sproutly may or may not get the rights to US, but they may certainly be the initial or long term provider to IBS should IBS not or need to apply for ACMPR/LP or equivalent licensing. Dr Sen could then continue to double dip with exclusive US APP rights and Sproutly production/other JV. This would provide Dr Sen the ability to continue R&D through Sproutly/THR with the piece of mind as the middle man that his tech is in good hands. That’s just my theory and a positive one at that for Sproutly and dear share holders.
-----
AI
